Skip to main content

What the FDA labels say about taking them together

Brivaracetam and carbamazepine

Brivaracetam's FDA label of August 20, 2026 names carbamazepine in its drug interactions section, and carbamazepine's label names brivaracetam too. The brivaracetam label: “Because of increased exposure to carbamazepine metabolite, if tolerability issues arise, consider reducing carbamazepine dosage in patients on concomitant BRIVIACT.”

Check it at the source: the brivaracetam FDA label on DailyMed (effective August 20, 2026, UCB, Inc.); the carbamazepine FDA label on DailyMed (effective August 20, 2026, Novartis Pharmaceuticals Corporation).

What does the brivaracetam label say about carbamazepine?

Brivaracetam label, drug interactions

Because of increased exposure to carbamazepine metabolite, if tolerability issues arise, consider reducing carbamazepine dosage in patients on concomitant BRIVIACT.

Source: FDA drug label (Briviact), NDA205836 (Ucb Inc), as published by UCB, Inc., effective August 20, 2026 (SPL set 3cf2f439-0e97-443e-8e33-25ecef616f6c), via openFDA; the full label on DailyMed

What does the carbamazepine label say about brivaracetam?

Carbamazepine label, drug interactions

Accordingly, the dosage of Tegretol should be adjusted and/or the plasma levels monitored when used concomitantly with loxapine, quetiapine, valproic acid, or brivaracetam.

Source: FDA drug label (Tegretol), Novartis Pharmaceuticals Corporation, effective August 20, 2026 (SPL set 8d409411-aa9f-4f3a-a52c-fbcb0c3ec053), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

16Brivaracetam generic labelers
42Carbamazepine generic labelers
BrivaracetamCarbamazepine
Labeled forSeizures and epilepsyBipolar disorder, Seizures and epilepsy
Boxed warningNoYes
Pharmacy cost (NADAC)$0.259 per tablet 100 mg tablet$0.119 per tablet 200 mg tablet
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?